Opendata, web and dolomites

SOLID SIGNED

Suppression of Organelle Defects in Human Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SOLID project word cloud

Explore the words cloud of the SOLID project. It provides you a very rough idea of what is the project "SOLID" about.

frustrations    contain    phenotypes    systematic    alter    groundbreaking    stratification    until    function    ultradeep    paradigm    platform    biological    mutations    revealing    urgently    interrogate    alongside    diseases    perturbed    query    initial    solid    organelle    departs    engineering    hurdles    machines    hundreds    haploid    hidden    malfunctioning    mapping    independent    diversity    therapeutic    neurodegeneration    cures    perturbation    mitochondria    exhaustive    yielding    correct    entirely    time    lysosomes    causative    amount    cellular    model    lacking    mutagenesis    biology    centric    absent    first    fitness    fidelity    cell    mutation    create    remove    limited    concerted    metabolic    altogether    view    questions    genetics    environmental    impaired    recessive    disease    organelles    relies    genome    mainly    uncover    incurable    uniquely    eukaryotic    triggers    strategies    direct    substantial    mutants    point    reveal    fashion    organisms    mostly    difficulty    human    functioning    fixed    suppression    captures    surveys    etiological    defects    suppressors    modules    genes    disorders    gene    drugging    extensive    possibilities    genetic    combines    instead    applicable    yeast    exemplified    suppressor   

Project "SOLID" data sheet

The following table provides information about the project.

Coordinator
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

Organization address
address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539
website: www.uni-muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙498˙400 €
 EC max contribution 1˙498˙400 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2024-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) coordinator 1˙498˙400.00

Map

 Project objective

The goal of SOLID is the systematic mapping of genetic suppression for important organelles with impaired fidelity in human disease to uncover new strategies to correct the perturbed state. Functioning of the eukaryotic cell relies on the concerted activity of biological machines, defects in which can cause incurable human disease, including metabolic disorders and neurodegeneration. This is exemplified by malfunctioning mitochondria or lysosomes, for which (alongside environmental triggers) hundreds of causative genes have been identified, but cures are mostly lacking. This is mainly due to the difficulty of drugging loss-of-function mutations, which uniquely alter or entirely remove the gene product. Extensive studies in yeast and initial work in the human system show that cellular modules contain a substantial amount of hidden genetic suppression. Revealing suppressors of disease-defining features of organelle perturbation and targeting those instead of the query mutations, will address the frustrations of drugging an absent factor and etiological diversity. Until now, mutation-based genome-wide suppressor surveys were mostly limited to model organisms and phenotypes yielding growth defects, due to technical hurdles associated with recessive genetics in the human system. However, with the development of a groundbreaking new forward genetics platform that combines genome engineering, ultradeep haploid mutagenesis and direct stratification of fixed mutants, we can now, for the first time, interrogate genetic suppression of human organelle defects independent of cellular fitness. SOLID will also develop new technology to study organelle fidelity in an exhaustive fashion that departs from a gene-centric view point and captures complex phenotypes. Altogether, this will create a new paradigm of 'studying cell biology via genetics' widely applicable to many different biological questions, and reveal urgently needed novel therapeutic possibilities for incurable diseases.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SOLID" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SOLID" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

CHIPTRANSFORM (2018)

On-chip optical communication with transformation optics

Read More  

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More  

AST (2019)

Automatic System Testing

Read More